The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...

The result comes shortly after Sarclisa was shown to add a benefit when added to another first-line multiple myeloma regimen for transplant-ineligible patients – VRd (Takeda’s Velcade ...

Among 1,000 selected compounds and antibiotics tested against all or portions of the tumor spectrum (33 tumors), cytoxan was the most effective, having a marked inhibitory to complete inhibitory ...

The use of "anno domini" and "before Christ" to mark time began in the early days of Christianity, and they're still used to track calendar years today. When reading historical texts or delving ...

Also make sure to check our part 1 of our exclusive interview with her regarding the recent FDA approval of isatuximab (Sarclisa; Sanofi-Aventis) plus bortezomib (Velcade; Takeda), lenalidomide ...

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP) ...

Sarclisa in combination with the VRd regiment was superior to VRd alone in improving survival in stem cell transplant ineligible multiple myeloma patients. No significant difference in serious adverse ...

Breast cancer treatment has evolved in recent years with a growing number of hormone therapies, targeted drugs, and immunotherapies supporting more traditional approaches, like surgery, radiation, and ...

Michael Boyle is an experienced financial professional with more than 10 years working with financial planning, derivatives, equities, fixed income, project management, and analytics. Suzanne is a ...

Cyclophosphamide (Cytoxan) is another type of oral chemotherapy that’s included in a combined treatment regimen called CMF (cyclophosphamide, methotrexate, fluorouracil). However ...